Forecast: Basic Pharmaceutical Products and Preparations Manufacturing Output in the Netherlands

The basic pharmaceutical products and preparations manufacturing output in the Netherlands has shown consistent growth over the last decade, with a notable increase from 2021 onwards. The actual output in 2023 stood at 10.32 Billion Euros, marking an 8.67% growth compared to the previous year. The Compound Annual Growth Rate (CAGR) over the past five years (2018-2023) has been approximately 12.2%.

From 2013 to 2023, the industry experienced fluctuating growth rates with some periods of decline, especially in 2017 and 2018. However, starting from 2019, the sector regained its momentum and continued its upward trajectory. This was particularly evident between 2021 and 2023, where the year-on-year growth rates were significantly high, demonstrating the sector's resilience and robust expansion.

The forecasted data from 2024 to 2028 indicates continued strong growth, with an expected CAGR of 5.02%. This suggests a steady yet smaller increase in comparison to the past five years' growth rate but still indicative of the sector’s evolution and potential.

Future trends to watch for in the basic pharmaceutical products and preparations manufacturing sector in the Netherlands include:

• Innovations in biotechnology and personalized medicine driving output increases.
• Increased investment in R&D to sustain growth and competitiveness.
• Potential regulatory changes impacting manufacturing processes and market access.
• Global health crises and their influence on pharmaceutical demand and production capacity.